MedPath

Clinical Evaluation of Topical Coenzyme Q10 in Management of Oral Aphthous Ulcer

Not Applicable
Conditions
Oral Aphthous Ulcer
Interventions
Drug: topical coenzyme Q10 gel
Drug: Carpabol gel
Registration Number
NCT03213769
Lead Sponsor
Cairo University
Brief Summary

Recurrent oral aphthous ulcer is the most common oral lesion in occurrence and one of cause is oxidative stress so investigators need to use antioxidant drugs like topical coenzyme Q10 gel to treat the lesion and more safe for the participants.

Detailed Description

Double randomized clinical trial study using two parallel group suffer from oral aphthous ulcer one take antioxidant topical q10gel and other group take placebo carpabol gel two times per day for seven days measuring outcome at fourth and seventh day including pain; healing period and clinical parameters.

Sample size of study include 26 in each group.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
52
Inclusion Criteria
  • Patients with free medical history and no systemic diseases16.
  • Patients clinically diagnosed as suffering from symptomatic oral minor aphthous ulcers.
  • Patients who agreed to take medications.
Read More
Exclusion Criteria
  • Patients suffering from any systemic disease as Crohn's disease, Behcet's disease and others.
  • Anemic and leukemic patients (using complete blood count investigation)
  • Patients taking systemic drugs such as systemic steroids and other immunosuppressive therapy.
  • Patients treated with any oral topical medications 48h before the study27.
  • Pregnant and lactating mothers.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
topical coenzyme Q10 geltopical coenzyme Q10 gelQ10 gel will give 2 times /day after breakfast and evening meal for 7 days.
carbapol gelCarpabol gelplacebo carbapol gel will give 2 times /day after breakfast and evening meal for 7 days.
Primary Outcome Measures
NameTimeMethod
visual analogue scale7 days

pain

Secondary Outcome Measures
NameTimeMethod
scoring system(0-3)7 days

Erythema surround lesion

cross sectional area William periodontal probe/mm7 days

Cross sectional area

© Copyright 2025. All Rights Reserved by MedPath